Our extensive database of Harvard technologies is available for new product development opportunities that will strengthen your strategic portfolio.

SEARCH

Category:

AVAILABLE TECHNOLOGIES - Oncology

Results: 25
Case # Lead Inventor Title
3469Sorger, Peter K.Knockout mouse model for human liver cancer
3358Corey, Elias J.Novel Antiangiogenic Agents Inspired by Cortistatin A: Next generation therapeutics for macular degeneration and cancer
3289Hu, GuofuUse of neamine for treating prostate cancer
3116Kassis, Amin I.Detection of Solid Tumor Signatures in Blood of Cancer Patients
2963Gygi, Steven P.A technology for a mass spectrometry-based in vitro kinome activity assay
2954Schreiber, Stuart L.Non-ATP competitive Inhibitors of Aurora Kinases: Selective and Potent Cancer Treatment
2887Qin, XuebinInhibitor of CD59 Activity as an Adjunct to Antibody-Based Cancer Therapy
2672Schreiber, Stuart L.Dimeric HDAC Inhibitors
2506Marsit, Carmen J.Detection of Invasive Bladder Cancer by DNA Hypermethylation
2438Myers, Andrew G.Natural Product Avrainvillamide and its Analogs as Targeted Anticancer Agents
2436Schreiber, Stuart L.Tubacin for Myeloma Therapy
2314Mazitschek, RalphSpecific Targeting of Cell Division (and Cancer): Small molecule inhibitors of Eg5 Hold Potential for Enhanced Safety
2230King, Randall W.A Novel Class of Proteosome Inhibitors
2193Myers, Andrew G.Saframycin Assay
2060Schreiber, Stuart L.Anti-Mitotic Eg5 Inhibitors for Treatment of Cancer and Inflammatory Disease
1917Schreiber, Stuart L.HDAC Inhibitors
1776Munger, KarlMethods to Regulate the Duration of Th2 Activation
1742Jones, Alun G.Next Generation Diagnostics for Breast Cancer, Prostate Cancer, and Melanoma
1675Schreiber, Stuart L.Identification and Characterization of Class II HDACs: Lead Targets for Treatment of Cancer and Neurodegenerative Diseases
1659Yuan, Zhi-MinIdentification of a Sequence Element from p53 that Signals for Mdm2-targeted Deg
1502Erikson, Raymond LeoPolo-Like Kinase Polo Box: Lead Target for Cancer Therapeutics
1365Fett, James W.Antisense Inhibition of Angiogenin Expression in Cancer
1250Schreiber, Stuart L.Identification and Characterization of Class II HDACs: Lead Targets for Treatment of Cancer and Neurodegenerative Diseases
1229Howley, Peter M.Gene Therapy For Papillomavirus Induced Cervical Carcinoma
1188Wong, David T. W.A Novel Tumor Suppressor Protein and Gene